Question follow-through · 100724
Cancer: Drugs
To ask the Secretary of State for Health and Social Care, whether his department has considered the impact of NICE’s severity modifier, introduced in 2020, on NHS England’s access to innovative cancer medicines which were previously eligible under the end
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 16 Dec 2025
- Target answer date
- 18 Dec 2025
- Answer
- 7 Jan 2026 · 22 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Cardiovascular Diseases: Health Services · 5 Jan 2026
- Bladder Cancer · 8 Jan 2026
- Infant Mortality: Bereavement Counselling · 3 Feb 2026
- Nutrition · 10 Feb 2026
- Bowel Cancer: Screening · 20 Feb 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
16 Dec 2025
Question tabled
To ask the Secretary of State for Health and Social Care, whether his department has considered the impact of NICE’s severity modifier, introduced in 2020, on NHS England’s access to innovative cancer medicines which were previously eligible under the end
18 Dec 2025
Target answer date
Date supplied by the official written-questions record.
7 Jan 2026
Answer published
The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes that it uses in the development of its recommendations. The severity modifier was introduced in January 2022 as part of a number of changes intended ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Cardiovascular Diseases: Health Services
5 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of introducing an equivalent of the EU Safe Hearts Plan in the UK.
Bladder Cancer
8 Jan 2026 · To ask the Secretary of State for Health and Social Care, what consideration he has made of the need for a national bladder cancer audit.
Infant Mortality: Bereavement Counselling
3 Feb 2026 · To ask the Secretary of State for Health and Social Care, what assessment his department has made of the findings of the Held in Our Hearts Impact Report on hospital-to-home bereavement support for families following the loss of a baby.
Nutrition
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of introducing the 2018 Nutrient Profiling Model on business investment in the food and drink sector.
Bowel Cancer: Screening
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the diagnostic and workforce capacity required to increase the test sensitivity threshold in the Bowel Cancer Screening Programme to 80ug/g by 2028.
Bowel Cancer: Screening
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, how his Department plans to support endoscopy services to ensure the increased test sensitivity in the Bowel Cancer Screening Programme to 80ug/g is rolled out by 2028 without impacting on colonosc
Consent to Medical Treatment
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of informed consent guidance in protecting NHS clinicians from subsequent legal challenge where animal-derived ingredients are used in medicines or treat
Food: Advertising
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, with reference to impact assessment 13013 published by his Department on 25 May 2021, whether his Department still plans to publish a review of the advertising and promotional restrictions within t
Consent to Medical Treatment
12 Mar 2026 · To ask the Secretary of State for Health and Social Care, further to the Written Answer given on 2 March 2026 (UIN 114544), does he plan to review or update this guidance.
Defibrillators
18 Mar 2026 · To ask the Secretary of State for Health and Social Care, whether he has considered introducing a national defibrillator strategy.
Heart Valve Disease: Health Services
19 Mar 2026 · To ask the Secretary of State for Health and Social Care, what consideration he has given to the use of existing delivery frameworks, such as the Major Conditions Strategy, to drive improvements in early detection and treatment of heart valve disease.
Heart Valve Disease: Diagnosis
19 Mar 2026 · To ask the Secretary of State for Health and Social Care, whether his Department has plans to develop a national strategy for the early detection of heart valve disease.